Your browser doesn't support javascript.
loading
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study.
Coates, Laura C; Nash, Peter; Kvien, Tore K; Gossec, Laure; Mease, Philip J; Rasouliyan, Lawrence; Pricop, Luminita; Jugl, Steffen M; Gandhi, Kunal K; Gaillez, Corine; Smolen, Josef S.
Afiliação
  • Coates LC; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research centre, Windmill Road, Oxford OX3 7LD, UK. Electronic address: laura.coates@ndorms.ox.ac.uk.
  • Nash P; School of Medicine, Griffith University, Brisbane, Australia.
  • Kvien TK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
  • Gossec L; Sorbonne Université, GRC08, Paris France; Pitié Salpêtrière Hospital, APHP, Rheumatology Department, Paris, France.
  • Mease PJ; Division of Rheumatology Research, Swedish Medical Center and University of Washington, Seattle, WA, USA.
  • Rasouliyan L; RTI Health Solutions, Barcelona, Spain.
  • Pricop L; Novartis Pharmaceuticals Corporation, East Hanover, USA.
  • Jugl SM; Novartis Pharma AG, Basel, Switzerland.
  • Gandhi KK; Novartis Pharmaceuticals Corporation, East Hanover, USA.
  • Gaillez C; Novartis Pharma AG, Basel, Switzerland.
  • Smolen JS; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria.
Semin Arthritis Rheum ; 50(4): 709-718, 2020 08.
Article em En | MEDLINE | ID: mdl-32521325
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Indução de Remissão / Artrite Psoriásica / Antirreumáticos / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Indução de Remissão / Artrite Psoriásica / Antirreumáticos / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2020 Tipo de documento: Article